Inflation eases to 26-month low in Jan
India's headline inflation slowed to its lowest level in more than two years in January as food prices fell, increasing the pressure on the RBI to cut rates to battle the country's economic slowdown. Full Article
Reuters Showcase
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
India Ranbaxy gets FDA nod for cyclobenzaprine HCL
U.S.'s next top dog
Two thousand dogs vie to be named "Best in Show" at New York's Westminster Kennel Club Dog Show. Slideshow
MUMBAI |
MUMBAI May 15 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd (RANB.BO) has received approval from the U.S. Food and Drug Administration for muscle relaxant cyclobenzaprine hydrochloride tablets, the regulator's website showed.
The FDA has also granted tentative approval to Lupin Pharmaceuticals Inc, a unit of Lupin Ltd (LUPN.BO), for ramipril capsules, used in treating cardiovascular disease and high blood pressure. (Reporting by Rina Chandran; Editing by John Mair)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters